词条 | Flemming Ørnskov |
释义 |
| image = | image_size = | name = Flemming Ørnskov | caption = | birth_name = | birth_date = {{birth based on age as of date |59|2017|09|04}}[1] | birth_place = | death_date = | death_place = | death_cause = | restingplace = | nationality = Danish | religion = | ethnicity = | residence = | education = | alma mater = University of Copenhagen INSEAD Harvard University | occupation = CEO, Shire plc | known for = | salary = US$10,326,000 (total compensation, 2016)[1] | networth = | spouse = | parents = | children = | relatives = | website = }} Flemming Ørnskov (born 1957/58) is a Danish businessman who has been the chief executive officer (CEO) of Shire plc, a FTSE 100 speciality biopharmaceutical company since 30 April 2013, succeeding Angus Russell.[1] He previously worked for Bayer. Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[2] References1. ^{{cite web|title=Shire chief finds right prescription for growth|url=https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10541777/Shire-chief-finds-right-prescription-for-growth.html|work=The Telegraph|accessdate=20 March 2014}} {{Authority control}}{{DEFAULTSORT:Ornskov, Flemming}}{{Denmark-bio-stub}}{{business-bio-stub}}2. ^1 2 {{cite web|title=Executive Profile: Flemming Ornskov |url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=226579754&ticker=SHP:LN|website=Bloomberg|accessdate=4 September 2017}} 7 : 1950s births|Living people|Year of birth missing (living people)|University of Copenhagen alumni|INSEAD alumni|Harvard School of Public Health alumni|Danish chief executives |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。